ADAR and acute lymphoblastic leukemia: Rivera and colleagues suggested that ADAR1 promotes the tumorigenesis of leukaemic initiating cells (LICs) and contributes to relapse in patients with T cell acute lymphoblastic leukaemia (T-ALL) [83].